We are live on ! Find out more
VRX

VALEANT PHARMACEUTICALS INTL
VRX

Delisted

VRX was delisted on the 27th of September, 2010.

Back to rankings

1 hedge funds and large institutions have $1.47K invested in VALEANT PHARMACEUTICALS INTL in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $1.21K → $1.47K (+$265)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
1
Sonora Investment Management
Arizona
$1.47K – – –

VRX Hedge Fund Activity: Q3 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VALEANT PHARMACEUTICALS INTL (VRX) for Q3 2016, worth a combined $1.47K — up 22% from $1.21K a quarter earlier.

Fund positioning in VRX was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held VALEANT PHARMACEUTICALS INTL (VRX) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $1.47K of VALEANT PHARMACEUTICALS INTL stock for Q3 2016, up 22% quarter-over-quarter.
  • 0 funds opened new VALEANT PHARMACEUTICALS INTL positions in Q3 2016 and 0 closed out.

Based on aggregated 13F filings for Q3 2016.